ArticleBJPsych open2025

A proof-of-concept study: investigating the impact of COMT genotype and proline on negative symptoms in Alzheimer's disease.

James D Clelland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.